| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Kenji Oritani | |
| Yuzuru Kanakura | |||
| P2860 | cites work | Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis | Q22253228 |
| EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes | Q22253257 | ||
| Limitin: An interferon-like cytokine that preferentially influences B-lymphocyte precursors | Q22254187 | ||
| Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells | Q24291206 | ||
| The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells | Q24292183 | ||
| Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G | Q24309656 | ||
| Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene | Q24313328 | ||
| Daxx, a Novel Fas-Binding Protein That Activates JNK and Apoptosis | Q24316216 | ||
| Physical and functional interactions between Daxx and TSG101 | Q24318359 | ||
| Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics | Q24672792 | ||
| The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein | Q28115603 | ||
| A protein tyrosine kinase in the interferon alpha/beta signaling pathway | Q28116574 | ||
| Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1 | Q28138171 | ||
| Identification of XAF1 as an antagonist of XIAP anti-Caspase activity | Q28200039 | ||
| Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor | Q78192827 | ||
| The role of PML in tumor suppression | Q28217779 | ||
| Physical and functional interactions between Daxx and DNA methyltransferase 1-associated protein, DMAP1 | Q28246253 | ||
| The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein | Q28255013 | ||
| A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells | Q28289338 | ||
| Interferons, interferon-like cytokines, and their receptors | Q28293630 | ||
| Interferon-zeta/limitin: novel type I interferon that displays a narrow range of biological activity | Q28299666 | ||
| CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors | Q28609404 | ||
| RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts | Q28646356 | ||
| Differential effects of a novel IFN-zeta/limitin and IFN-alpha on signals for Daxx induction and Crk phosphorylation that couple with growth control of megakaryocytes | Q33365494 | ||
| Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L | Q33887630 | ||
| Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. | Q33967257 | ||
| Interaction of the c-cbl proto-oncogene product with the Tyk-2 protein tyrosine kinase | Q34063147 | ||
| Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis | Q34130066 | ||
| Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities | Q34132119 | ||
| Limitin: an interferon-like cytokine without myeloerythroid suppressive properties | Q34284685 | ||
| Type I interferons and limitin: a comparison of structures, receptors, and functions | Q34360681 | ||
| Interferon alfacon-1: a review of its pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C. | Q34385411 | ||
| Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53. | Q35197148 | ||
| Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1. | Q35802799 | ||
| An essential role for Daxx in the inhibition of B lymphopoiesis by type I interferons | Q38299652 | ||
| Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex | Q38812104 | ||
| Alpha and beta interferons and their receptor and their friends and relations. | Q40467356 | ||
| A new interferon, limitin, displays equivalent immunomodulatory and antitumor activities without myelosuppressive properties as compared with interferon-alpha | Q40519547 | ||
| Characterization of N-terminal interferon tau mutants: P26L affords enhanced activity and lack of toxicity | Q40597222 | ||
| Limitin, an interferon-like cytokine, transduces inhibitory signals on B-cell growth through activation of Tyk2, but not Stat1, followed by induction and nuclear translocation of Daxx. | Q40609503 | ||
| Domains of interaction between alpha interferon and its receptor components | Q40636143 | ||
| Daxx enhances Fas-mediated apoptosis in a murine pro-B cell line, BAF3. | Q40656671 | ||
| Cutting edge: tyk2 is required for the induction and nuclear translocation of Daxx which regulates IFN-alpha-induced suppression of B lymphocyte formation. | Q40695619 | ||
| Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta | Q40794190 | ||
| Stat-1 is not essential for inhibition of B lymphopoiesis by type I IFNs | Q40860970 | ||
| p95(vav) associates with the type I interferon (IFN) receptor and contributes to the antiproliferative effect of IFN-alpha in megakaryocytic cell lines | Q40902835 | ||
| The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx | Q40944377 | ||
| Safety profile of interferon-alpha therapy. | Q41712606 | ||
| T lymphocytes constitutively produce an interferonlike cytokine limitin characterized as a heat- and acid-stable and heparin-binding glycoprotein | Q42686286 | ||
| Regulatable expression of the interferon-induced double-stranded RNA dependent protein kinase PKR induces apoptosis and fas receptor expression | Q42817357 | ||
| A new IFN-like cytokine, limitin, modulates the immune response without influencing thymocyte development | Q43729109 | ||
| Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis | Q43843414 | ||
| Mapping of two immunodominant structures on human interferon alpha 2c and their role in binding to cells | Q44132267 | ||
| Different functional sites on rIFN-alpha 2 and their relation to the cellular receptor binding site | Q44564315 | ||
| Amantadine and interferon in the combined treatment of hepatitis C virus in elderly patients | Q45733443 | ||
| Are all type I human interferons equivalent? | Q47866316 | ||
| Differences in Activity between α and β Type I Interferons Explored by Mutational Analysis | Q58460123 | ||
| An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes | Q59067290 | ||
| Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage | Q59081725 | ||
| Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function | Q71984887 | ||
| Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C | Q73427465 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 244-254 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | IFN-zeta/ limitin: a member of type I IFN with mild lympho-myelosuppression | |
| P478 | volume | 9 |
| Q37295187 | A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect |
| Q38748641 | Antitumour actions of interferons: implications for cancer therapy |
| Q90011071 | Inflammatory bowel disease pathobiology: the role of the interferon signature |
| Q28238963 | Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses |
| Q35483420 | Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy |
| Q35034672 | Modulation of interferon activity-associated soluble molecules by appendicitis and appendectomy limits colitis-identification of novel anti-colitic targets |
| Q34384616 | Structural analysis of cytokines comprising the IL-10 family |
| Q36137937 | TIR Domain-Containing Adapter-Inducing Beta Interferon (TRIF) Mediates Immunological Memory against Bacterial Pathogens |
Search more.